|
To view this message in your browser please click here
|
 |
Introducing our online catalogue of Affimers - engineered affinity proteins. |
 |
|
 |
Affimers are revolutionary new affinity proteins that have been designed to address many of the negative performance issues experienced with antibodies such as poor specificity, batch-to-batch variation and the long time taken to generate new antibodies.
|
|
Affimers benefit from being small, robust and very stable. They are not limited by the immune system and are generated without the use of animals. Affimer technology is proprietary to Avacta Life Sciences and therefore licensing is straightforward.
|
|
Affimers are not nucleic acid aptamers, so they are high affinity, stable reagents that can be used as a direct replacement for antibodies with no changes to your workflow.
|
|
Unlocking the door to new research |
|
The Affimer catalogue contains binders to targets for which antibodies cannot be generated, such as ubiquitylation chains, as well as binders to more common targets and workhorse reagents. Switching from antibodies to Affimers requires no change in working procedures - making it a simple
like-for-like swap.
|
|
The Affimer catalogue will provide a comprehensive toolkit for robust detection, discovery and validation of new disease biomarkers and drug targets, and for a range of other applications across life sciences research and development.
|
|
Find out more
|
|
View our website and purchase these revolutionary new life sciences tools.
|
|
|
View catalogue
|
|
Click here to view our online catalogue.
|
|
|
|
 |
|
|
